Inventor
MUSICKI BRANISLAV
FR24 patents
⚠️ This page may combine multiple inventors who share the name “MUSICKI BRANISLAV”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GALDERMA RES & DEV
14 patentsUS9650337B2May 16, 2017
Method of synthesising 4-piperidin-4-yl-benzene-1,3-diol and the salts of same and novel compound tert-butyl 4-(2,4-dihydroxy-phenyl)-4-hydroxy-piperidine-1-carboxylate
GALDERMA RES & DEV3 citations72
US10246440B2Apr 2, 2019
Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR γ (T))
GALDERMA RES & DEV2 citations71
US9090596B2Jul 28, 2015
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
GALDERMA RES & DEV3 citations60
US10752617B2Aug 25, 2020
Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))
GALDERMA RES & DEV0 citations51
US10618890B2Apr 14, 2020
Benzimidazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T))
GALDERMA RES & DEV0 citations51
US10550110B2Feb 4, 2020
Tetrahydroquinoline sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (t))
GALDERMA RES & DEV0 citations51
US9580412B2Feb 28, 2017
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
GALDERMA RES & DEV1 citations49
US9526732B2Dec 27, 2016
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
GALDERMA RES & DEV1 citations49
US9415039B2Aug 16, 2016
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
GALDERMA RES & DEV0 citations49
US9120772B2Sep 1, 2015
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
GALDERMA RES & DEV0 citations49
US10647706B2May 12, 2020
Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies
GALDERMA RES & DEV0 citations48
US10287278B2May 14, 2019
Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies
GALDERMA RES & DEV0 citations48
US9388149B2Jul 12, 2016
Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
GALDERMA RES & DEV1 citations46
US10457637B2Oct 29, 2019
Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (RORγ(T))
GALDERMA RES & DEV0 citations40
AVENTIS PHARMA SA
6 patentsUS6579902B1Jun 17, 2003
Ribose-substituted aromatic amides, method for the production and use thereof as medicaments
AVENTIS PHARMA SA21 citations91
US7288549B2Oct 30, 2007
Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as antibacterial agents
AVENTIS PHARMA SA26 citations89
US6420538B1Jul 16, 2002
Aromatic amides, preparation method and application as medicines
AVENTIS PHARMA SA7 citations70
US6812331B2Nov 2, 2004
Aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments
AVENTIS PHARMA SA4 citations60
US6350733B1Feb 26, 2002
Aromatic derivatives substituted by a ribose, their method of preparation and application as medicine
AVENTIS PHARMA SA4 citations60
US6583119B2Jun 24, 2003
Aromatic amides, preparation method and application as medicines
AVENTIS PHARMA SA5 citations59